Skip to Content
Clinical Guidelines

NICE has renewed accreditation of the process used by the British Association of Dermatologists to produce clinical guidelines. The accreditation recognises the stringent protocol that the BAD employs in producing clinical guidelines.

The renewed accreditation is valid until 31st May 2021 and applies to guidance produced using the processes described in 'Updated guidance for writing a British Association of Dermatologists clinical guideline - the adoption of the GRADE methodology 2016'.

The original accreditation term began on 12th May 2010 and retrospectively covered guidelines that were accepted for publication from September 2008.

The accreditation means that future BAD guidelines will not only need to follow the accredited process manual strictly, but also fulfill all of the 25 criteria set by NICE in order to maintain the BAD's status as an accredited guidance producer (please click here for the NICE guidelines checklist).

Further information on the BAD's accreditation decision can be found on the NICE accreditation portal.

All guidelines are freely available via the British Journal of Dermatology website.

Close
Isotretinoin (Acne)

Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010

Goodfield MJD, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, Ormerod AD. Br J Dermatol 2010; 162: 1172-1179.

“The British Association of Dermatologists decided not to update this guideline (see Archive Clinical Guidelines page) due to the publication of the National Institute for Health and Care Research (NICE) guideline Acne vulgaris: management (NG198)

Isotretinoin PIL available via SkinHealthInfo website.

Back to top